Humacyte, Inc. — Director's Dealing 2024

Jun 3, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Humacyte, Inc. (HUMA)
CIK: 0001818382
Period of Report: 2024-06-03

Reporting Person: Dougan Brady W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-06-03	Common Stock	P	2050	$7.37	Acquired	238470	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	510161	Direct
Common Stock	1148240	Indirect
Common Stock	6191140	Indirect

Footnotes

F1: Reflects a transfer of 1,148,240 shares of common stock by Laura E. Niklason to The Niklason Living Trust on April 19, 2024, which was exempt from reporting under Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.